世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Palbociclib Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5925
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・パルボシクリブ薬の市場動向
・企業の競争状況、市場シェア
・パルボシクリブ薬の種類別市場規模と予測2016-2027（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）
・パルボシクリブ薬の用途別市場規模と予測2016-2027（病院、診断センター、研究所）
・パルボシクリブ薬の北米市場規模2016-2027（アメリカ、カナダ）
・パルボシクリブ薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・パルボシクリブ薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・パルボシクリブ薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・パルボシクリブ薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Beacon Pharmaceuticals、Incepta Pharmaceuticals、Bluepharma、NANO DARU）
・結論

Palbociclib is a drug manufactured by Pfizer, marketed under the brand Ibrance, and it is used for the treatment of hormone receptor-positive (HR+ve) and human epidermal growth factor receptor 2-negative (HER2-), advanced or metastatic breast cancer. It inhibits the activity of cyclin dependent kinases, specifically CDK4 and CDK8, thus preventing the growth of cancer cells.

Market Analysis and Insights: Global Palbociclib Drug Market
The global Palbociclib Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Palbociclib Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Palbociclib Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Palbociclib Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Palbociclib Drug market.

Global Palbociclib Drug Scope and Market Size
Palbociclib Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Palbociclib Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets Type Palbociclib Drug
Capsules Type Palbociclib Drug

Segment by Application
Hospitals
Diagnostic Centers
Research Institutes

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Beacon Pharmaceuticals
Incepta Pharmaceuticals
Bluepharma
NANO DARU

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Palbociclib Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets Type Palbociclib Drug
1.2.3 Capsules Type Palbociclib Drug
1.3 Market by Application
1.3.1 Global Palbociclib Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Palbociclib Drug Market Perspective (2016-2027)
2.2 Palbociclib Drug Growth Trends by Regions
2.2.1 Palbociclib Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Palbociclib Drug Historic Market Share by Regions (2016-2021)
2.2.3 Palbociclib Drug Forecasted Market Size by Regions (2022-2027)
2.3 Palbociclib Drug Industry Dynamic
2.3.1 Palbociclib Drug Market Trends
2.3.2 Palbociclib Drug Market Drivers
2.3.3 Palbociclib Drug Market Challenges
2.3.4 Palbociclib Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Palbociclib Drug Players by Revenue
3.1.1 Global Top Palbociclib Drug Players by Revenue (2016-2021)
3.1.2 Global Palbociclib Drug Revenue Market Share by Players (2016-2021)
3.2 Global Palbociclib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Palbociclib Drug Revenue
3.4 Global Palbociclib Drug Market Concentration Ratio
3.4.1 Global Palbociclib Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Palbociclib Drug Revenue in 2020
3.5 Palbociclib Drug Key Players Head office and Area Served
3.6 Key Players Palbociclib Drug Product Solution and Service
3.7 Date of Enter into Palbociclib Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Palbociclib Drug Breakdown Data by Type
4.1 Global Palbociclib Drug Historic Market Size by Type (2016-2021)
4.2 Global Palbociclib Drug Forecasted Market Size by Type (2022-2027)

5 Palbociclib Drug Breakdown Data by Application
5.1 Global Palbociclib Drug Historic Market Size by Application (2016-2021)
5.2 Global Palbociclib Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Palbociclib Drug Market Size (2016-2027)
6.2 North America Palbociclib Drug Market Size by Type
6.2.1 North America Palbociclib Drug Market Size by Type (2016-2021)
6.2.2 North America Palbociclib Drug Market Size by Type (2022-2027)
6.2.3 North America Palbociclib Drug Market Size by Type (2016-2027)
6.3 North America Palbociclib Drug Market Size by Application
6.3.1 North America Palbociclib Drug Market Size by Application (2016-2021)
6.3.2 North America Palbociclib Drug Market Size by Application (2022-2027)
6.3.3 North America Palbociclib Drug Market Size by Application (2016-2027)
6.4 North America Palbociclib Drug Market Size by Country
6.4.1 North America Palbociclib Drug Market Size by Country (2016-2021)
6.4.2 North America Palbociclib Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Palbociclib Drug Market Size (2016-2027)
7.2 Europe Palbociclib Drug Market Size by Type
7.2.1 Europe Palbociclib Drug Market Size by Type (2016-2021)
7.2.2 Europe Palbociclib Drug Market Size by Type (2022-2027)
7.2.3 Europe Palbociclib Drug Market Size by Type (2016-2027)
7.3 Europe Palbociclib Drug Market Size by Application
7.3.1 Europe Palbociclib Drug Market Size by Application (2016-2021)
7.3.2 Europe Palbociclib Drug Market Size by Application (2022-2027)
7.3.3 Europe Palbociclib Drug Market Size by Application (2016-2027)
7.4 Europe Palbociclib Drug Market Size by Country
7.4.1 Europe Palbociclib Drug Market Size by Country (2016-2021)
7.4.2 Europe Palbociclib Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Palbociclib Drug Market Size (2016-2027)
8.2 Asia-Pacific Palbociclib Drug Market Size by Type
8.2.1 Asia-Pacific Palbociclib Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Palbociclib Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Palbociclib Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Palbociclib Drug Market Size by Application
8.3.1 Asia-Pacific Palbociclib Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Palbociclib Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Palbociclib Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Palbociclib Drug Market Size by Region
8.4.1 Asia-Pacific Palbociclib Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Palbociclib Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Palbociclib Drug Market Size (2016-2027)
9.2 Latin America Palbociclib Drug Market Size by Type
9.2.1 Latin America Palbociclib Drug Market Size by Type (2016-2021)
9.2.2 Latin America Palbociclib Drug Market Size by Type (2022-2027)
9.2.3 Latin America Palbociclib Drug Market Size by Type (2016-2027)
9.3 Latin America Palbociclib Drug Market Size by Application
9.3.1 Latin America Palbociclib Drug Market Size by Application (2016-2021)
9.3.2 Latin America Palbociclib Drug Market Size by Application (2022-2027)
9.3.3 Latin America Palbociclib Drug Market Size by Application (2016-2027)
9.4 Latin America Palbociclib Drug Market Size by Country
9.4.1 Latin America Palbociclib Drug Market Size by Country (2016-2021)
9.4.2 Latin America Palbociclib Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Palbociclib Drug Market Size (2016-2027)
10.2 Middle East & Africa Palbociclib Drug Market Size by Type
10.2.1 Middle East & Africa Palbociclib Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Palbociclib Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Palbociclib Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Palbociclib Drug Market Size by Application
10.3.1 Middle East & Africa Palbociclib Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Palbociclib Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Palbociclib Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Palbociclib Drug Market Size by Country
10.4.1 Middle East & Africa Palbociclib Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Palbociclib Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Palbociclib Drug Introduction
11.1.4 Pfizer Revenue in Palbociclib Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Beacon Pharmaceuticals
11.2.1 Beacon Pharmaceuticals Company Details
11.2.2 Beacon Pharmaceuticals Business Overview
11.2.3 Beacon Pharmaceuticals Palbociclib Drug Introduction
11.2.4 Beacon Pharmaceuticals Revenue in Palbociclib Drug Business (2016-2021)
11.2.5 Beacon Pharmaceuticals Recent Development
11.3 Incepta Pharmaceuticals
11.3.1 Incepta Pharmaceuticals Company Details
11.3.2 Incepta Pharmaceuticals Business Overview
11.3.3 Incepta Pharmaceuticals Palbociclib Drug Introduction
11.3.4 Incepta Pharmaceuticals Revenue in Palbociclib Drug Business (2016-2021)
11.3.5 Incepta Pharmaceuticals Recent Development
11.4 Bluepharma
11.4.1 Bluepharma Company Details
11.4.2 Bluepharma Business Overview
11.4.3 Bluepharma Palbociclib Drug Introduction
11.4.4 Bluepharma Revenue in Palbociclib Drug Business (2016-2021)
11.4.5 Bluepharma Recent Development
11.5 NANO DARU
11.5.1 NANO DARU Company Details
11.5.2 NANO DARU Business Overview
11.5.3 NANO DARU Palbociclib Drug Introduction
11.5.4 NANO DARU Revenue in Palbociclib Drug Business (2016-2021)
11.5.5 NANO DARU Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Palbociclib Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets Type Palbociclib Drug
Table 3. Key Players of Capsules Type Palbociclib Drug
Table 4. Global Palbociclib Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Palbociclib Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Palbociclib Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Palbociclib Drug Market Share by Regions (2016-2021)
Table 8. Global Palbociclib Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Palbociclib Drug Market Share by Regions (2022-2027)
Table 10. Palbociclib Drug Market Trends
Table 11. Palbociclib Drug Market Drivers
Table 12. Palbociclib Drug Market Challenges
Table 13. Palbociclib Drug Market Restraints
Table 14. Global Palbociclib Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Palbociclib Drug Market Share by Players (2016-2021)
Table 16. Global Top Palbociclib Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Palbociclib Drug as of 2020)
Table 17. Ranking of Global Top Palbociclib Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Palbociclib Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Palbociclib Drug Product Solution and Service
Table 21. Date of Enter into Palbociclib Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Palbociclib Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Palbociclib Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Palbociclib Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Palbociclib Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Palbociclib Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Palbociclib Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Palbociclib Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Palbociclib Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Palbociclib Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Palbociclib Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Palbociclib Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Palbociclib Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Palbociclib Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Palbociclib Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Palbociclib Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Palbociclib Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Palbociclib Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Palbociclib Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Palbociclib Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Palbociclib Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Palbociclib Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Palbociclib Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Palbociclib Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Palbociclib Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Palbociclib Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Palbociclib Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Palbociclib Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Palbociclib Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Palbociclib Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Palbociclib Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Palbociclib Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Palbociclib Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Palbociclib Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Palbociclib Drug Product
Table 64. Pfizer Revenue in Palbociclib Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Beacon Pharmaceuticals Company Details
Table 67. Beacon Pharmaceuticals Business Overview
Table 68. Beacon Pharmaceuticals Palbociclib Drug Product
Table 69. Beacon Pharmaceuticals Revenue in Palbociclib Drug Business (2016-2021) & (US$ Million)
Table 70. Beacon Pharmaceuticals Recent Development
Table 71. Incepta Pharmaceuticals Company Details
Table 72. Incepta Pharmaceuticals Business Overview
Table 73. Incepta Pharmaceuticals Palbociclib Drug Product
Table 74. Incepta Pharmaceuticals Revenue in Palbociclib Drug Business (2016-2021) & (US$ Million)
Table 75. Incepta Pharmaceuticals Recent Development
Table 76. Bluepharma Company Details
Table 77. Bluepharma Business Overview
Table 78. Bluepharma Palbociclib Drug Product
Table 79. Bluepharma Revenue in Palbociclib Drug Business (2016-2021) & (US$ Million)
Table 80. Bluepharma Recent Development
Table 81. NANO DARU Company Details
Table 82. NANO DARU Business Overview
Table 83. NANO DARU Palbociclib Drug Product
Table 84. NANO DARU Revenue in Palbociclib Drug Business (2016-2021) & (US$ Million)
Table 85. NANO DARU Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Palbociclib Drug Market Share by Type: 2020 VS 2027
Figure 2. Tablets Type Palbociclib Drug Features
Figure 3. Capsules Type Palbociclib Drug Features
Figure 4. Global Palbociclib Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Palbociclib Drug Report Years Considered
Figure 9. Global Palbociclib Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Palbociclib Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Palbociclib Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Palbociclib Drug Market Share by Regions (2022-2027)
Figure 13. Global Palbociclib Drug Market Share by Players in 2020
Figure 14. Global Top Palbociclib Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Palbociclib Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Palbociclib Drug Revenue in 2020
Figure 16. Global Palbociclib Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Palbociclib Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Palbociclib Drug Market Share by Type (2016-2027)
Figure 20. North America Palbociclib Drug Market Share by Application (2016-2027)
Figure 21. North America Palbociclib Drug Market Share by Country (2016-2027)
Figure 22. United States Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Palbociclib Drug Market Share by Type (2016-2027)
Figure 26. Europe Palbociclib Drug Market Share by Application (2016-2027)
Figure 27. Europe Palbociclib Drug Market Share by Country (2016-2027)
Figure 28. Germany Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Palbociclib Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Palbociclib Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Palbociclib Drug Market Share by Region (2016-2027)
Figure 38. China Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Palbociclib Drug Market Share by Type (2016-2027)
Figure 46. Latin America Palbociclib Drug Market Share by Application (2016-2027)
Figure 47. Latin America Palbociclib Drug Market Share by Country (2016-2027)
Figure 48. Mexico Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Palbociclib Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Palbociclib Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Palbociclib Drug Market Share by Country (2016-2027)
Figure 54. Turkey Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Palbociclib Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Palbociclib Drug Business (2016-2021)
Figure 58. Beacon Pharmaceuticals Revenue Growth Rate in Palbociclib Drug Business (2016-2021)
Figure 59. Incepta Pharmaceuticals Revenue Growth Rate in Palbociclib Drug Business (2016-2021)
Figure 60. Bluepharma Revenue Growth Rate in Palbociclib Drug Business (2016-2021)
Figure 61. NANO DARU Revenue Growth Rate in Palbociclib Drug Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の抗レトロウイルス薬市場規模・現状・予測（2021年-2027年）

Global Antiretroviral Drug Market Size, Status and Forecast 2021-2027
QFJ1-5589 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗レトロウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他）、用途別市場規模（病院、製薬会社、その他）、主要地域別市場規模（北米、アメ...

世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Drug Market Size, Status and Forecast 2021-2027
QFJ1-3865 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他）、用途別市場規模（小売薬局、病院薬局、オンライン...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027
QFJ1-4082 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027
QFJ1-5776 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、...

世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5777 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）...

世界の鎮痙薬市場規模・現状・予測（2021年-2027年）

Global Antispasmodics Drug Market Size, Status and Forecast 2021-2027
QFJ1-3839 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、鎮痙薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジシクロミン塩酸塩、ロペラミド塩酸塩、その他）、用途別市場規模（病院、ホームケア、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界の向精神薬市場規模・現状・予測（2021年-2027年） The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Market Analysis and Insights: Global Psychotropic Drug Market The global Psychotropic Drug market size is projec…
世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界の診断用核医薬品市場規模・現状・予測（2021年-2027年） Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis Market Analysis and Insights: Global Diagnostic Nuclear Drug Market The global Diagnostic Nuclear Drug market si…